Vyndaqel (tafamidis)

pCPA File Number: 21191
Negotiation Status:
Concluded with an LOI
Indication(s):
transthyretin-mediated amyloidosis
Sponsor/Manufacturer:
Pfizer Canada ULC
CADTH Project Number:
SR0625-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: